Advertisement

Topics

Generex Provides Access Information for Investor Conference Call Scheduled for February 22, 2017

09:30 EST 21 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Generex Biotechnology Corporation (OTCPink:GNBT) today announced the following access information for its investor conference call, to be hosted by Joseph Moscato, Company President & Chief Executive Officer, and his managem...

Other Sources for this Article

Generex Biotechnology Corporation
Joseph Moscato, 646-599-6222
or
Todd Falls, 800-391-6755 Extension 222
investor@generex.com

NEXT ARTICLE

More From BioPortfolio on "Generex Provides Access Information for Investor Conference Call Scheduled for February 22, 2017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...